CytRx announces data from Phase 1b trial of aldoxorubicin
Yahoo/Fly on the Wall
CytRx announces favorable results for clinical trial for aldoxorubicin
Yahoo/Fly on the Wall
CytRx initiates Phase 1b trial with combination Aldoxorubicin, Doxorubicin
The Fly on the Wall
CytRx falls 12% in morning trading
Marketwatch
CytRx Announces Favorable Results from Phase 1b/2 Clinical Trial with INNO-206
Yahoo/Business Wire
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
What Can We Expect From CytRx In 2012?
Seeking Alpha
Why CytRx Corporation Is Still A Big Biotech 'If' Play
Seeking Alpha

